UMI Fundamental Analysis - UMICORE

Fundamental Rating

Overall UMI gets a fundamental rating of 4 out of 10. We evaluated UMI against 66 industry peers in the Chemicals industry. UMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. UMI has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

UMI had positive earnings in the past year.

UMI had a positive operating cash flow in the past year.

Of the past 5 years UMI 4 years were profitable.

Each year in the past 5 years UMI had a positive operating cash flow.

1.2 Ratios

The Return On Assets of UMI (1.50%) is comparable to the rest of the industry.

Looking at the Return On Equity, with a value of 6.30%, UMI is in the better half of the industry, outperforming 62.12% of the companies in the same industry.

With a decent Return On Invested Capital value of 6.40%, UMI is doing good in the industry, outperforming 69.70% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	1.5%
ROE	6.3%
ROIC	6.4%

ROA(3y)-2.04%

ROA(5y)0.46%

ROE(3y)-16.55%

ROE(5y)-4.93%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of UMI (0.80%) is comparable to the rest of the industry.

UMI has a Operating Margin (2.57%) which is comparable to the rest of the industry.

UMI has a worse Gross Margin (7.76%) than 84.85% of its industry peers.

UMI's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	2.57%
PM (TTM)	0.8%
GM	7.76%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y6.61%

GM growth 5Y5.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UMI is still creating some value.

The number of shares outstanding for UMI remains at a similar level compared to 1 year ago.

UMI has about the same amout of shares outstanding than it did 5 years ago.

UMI has a worse debt/assets ratio than last year.

2.2 Solvency

UMI has an Altman-Z score of 2.71. This is not the best score and indicates that UMI is in the grey zone with still only limited risk for bankruptcy at the moment.

The Altman-Z score of UMI (2.71) is better than 71.21% of its industry peers.

The Debt to FCF ratio of UMI is 50.79, which is on the high side as it means it would take UMI, 50.79 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 50.79, UMI is in line with its industry, outperforming 42.42% of the companies in the same industry.

UMI has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.

UMI's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. UMI is outperformed by 81.82% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.1
Debt/FCF	50.79
Altman-Z	2.71

ROIC/WACC1.05

WACC6.12%

2.3 Liquidity

UMI has a Current Ratio of 1.37. This is a normal value and indicates that UMI is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of UMI (1.37) is worse than 71.21% of its industry peers.

UMI has a Quick Ratio of 1.37. This is a bad value and indicates that UMI is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of UMI (0.72) is worse than 83.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.37
Quick Ratio	0.72

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for UMI have decreased strongly by -18.12% in the last year.

UMI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.85% yearly.

Looking at the last year, UMI shows a small growth in Revenue. The Revenue has grown by 2.55% in the last year.

Measured over the past years, UMI shows a decrease in Revenue. The Revenue has been decreasing by -3.21% on average per year.

EPS 1Y (TTM)-18.12%

EPS 3Y-27.4%

EPS 5Y-3.85%

EPS Q2Q%14.29%

Revenue 1Y (TTM)2.55%

Revenue growth 3Y-14.84%

Revenue growth 5Y-3.21%

Sales Q2Q%-0.72%

3.2 Future

The Earnings Per Share is expected to grow by 7.13% on average over the next years.

UMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.45% yearly.

EPS Next Y19.7%

EPS Next 2Y12.28%

EPS Next 3Y10.35%

EPS Next 5Y7.13%

Revenue Next Year-2.5%

Revenue Next 2Y2.11%

Revenue Next 3Y1.65%

Revenue Next 5Y1.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.46, the valuation of UMI can be described as very reasonable.

Compared to the rest of the industry, the Price/Earnings ratio of UMI indicates a rather cheap valuation: UMI is cheaper than 90.91% of the companies listed in the same industry.

UMI is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.

With a Price/Forward Earnings ratio of 9.69, the valuation of UMI can be described as very reasonable.

Compared to the rest of the industry, the Price/Forward Earnings ratio of UMI indicates a rather cheap valuation: UMI is cheaper than 89.39% of the companies listed in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 22.70. UMI is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	11.46
Fwd PE	9.69

4.2 Price Multiples

68.18% of the companies in the same industry are more expensive than UMI, based on the Enterprise Value to EBITDA ratio.

The rest of the industry has a similar Price/Free Cash Flow ratio as UMI.

		Industry Rank	Sector Rank
P/FCF	56.57
EV/EBITDA	7.11

4.3 Compensation for Growth

UMI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.58

PEG (5Y)N/A

EPS Next 2Y12.28%

EPS Next 3Y10.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

UMI has a Yearly Dividend Yield of 2.65%.

Compared to an average industry Dividend Yield of 3.04, UMI pays a bit more dividend than its industry peers.

Compared to an average S&P500 Dividend Yield of 2.38, UMI has a dividend comparable with the average S&P500 company.

		Industry Rank	Sector Rank
Dividend Yield	2.65%

5.2 History

The dividend of UMI has a limited annual growth rate of 0.67%.

Dividend Growth(5Y)0.67%

Div Incr Years0

Div Non Decr Years4

5.3 Sustainability

93.29% of the earnings are spent on dividend by UMI. This is not a sustainable payout ratio.

UMI's earnings are growing more than its dividend. This makes the dividend growth sustainable.

DP93.29%

EPS Next 2Y12.28%

EPS Next 3Y10.35%

More info and screens

Find the best dividend stocks

Show peers with best dividend

UMICORE

EBR:UMI (9/18/2025, 9:31:49 AM)

12.95

-0.11 (-0.84%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)08-01 2025-08-01/bmo

Earnings (Next)02-03 2026-02-03/amc

Inst Owners38.34%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap3.19B

Analysts66.67

Price Target14.25 (10.04%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.65%

Yearly Dividend0.8

Dividend Growth(5Y)0.67%

DP93.29%

Div Incr Years0

Div Non Decr Years4

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)2.19%

PT rev (3m)27.46%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)24.09%

EPS NY rev (3m)24.09%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.03%

Revenue NY rev (3m)2.98%

Valuation

		Industry Rank	Sector Rank
PE	11.46
Fwd PE	9.69
P/S	0.2
P/FCF	56.57
P/OCF	6.79
P/B	1.56
P/tB	1.92
EV/EBITDA	7.11

EPS(TTM)1.13

EY8.73%

EPS(NY)1.34

Fwd EY10.32%

FCF(TTM)0.23

FCFY1.77%

OCF(TTM)1.91

OCFY14.72%

SpS65.35

BVpS8.29

TBVpS6.75

PEG (NY)0.58

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.5%
ROE	6.3%
ROCE	8.18%
ROIC	6.4%
ROICexc	8.19%
ROICexgc	9.07%
OM	2.57%
PM (TTM)	0.8%
GM	7.76%
FCFM	0.35%

ROA(3y)-2.04%

ROA(5y)0.46%

ROE(3y)-16.55%

ROE(5y)-4.93%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y6.61%

GM growth 5Y5.16%

F-Score5

Asset Turnover1.87

Health

		Industry Rank	Sector Rank
Debt/Equity	1.1
Debt/FCF	50.79
Debt/EBITDA	3.22
Cap/Depr	144.97%
Cap/Sales	2.57%
Interest Coverage	4.12
Cash Conversion	67.19%
Profit Quality	43.79%
Current Ratio	1.37
Quick Ratio	0.72
Altman-Z	2.71

F-Score5

WACC6.12%

ROIC/WACC1.05

Cap/Depr(3y)224.12%

Cap/Depr(5y)196.78%

Cap/Sales(3y)3.57%

Cap/Sales(5y)2.91%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-18.12%

EPS 3Y-27.4%

EPS 5Y-3.85%

EPS Q2Q%14.29%

EPS Next Y19.7%

EPS Next 2Y12.28%

EPS Next 3Y10.35%

EPS Next 5Y7.13%

Revenue 1Y (TTM)2.55%

Revenue growth 3Y-14.84%

Revenue growth 5Y-3.21%

Sales Q2Q%-0.72%

Revenue Next Year-2.5%

Revenue Next 2Y2.11%

Revenue Next 3Y1.65%

Revenue Next 5Y1.45%

EBIT growth 1Y136.32%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year55.35%

EBIT Next 3Y19.67%

EBIT Next 5Y16.26%

FCF growth 1Y136.84%

FCF growth 3Y-30.19%

FCF growth 5YN/A

OCF growth 1Y-3.36%

OCF growth 3Y-11.62%

OCF growth 5Y12.64%

UMICORE (UMI.BR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens